TrialClinical and translational science2026
Garadacimab in Hereditary Angioedema: Modeling Suggests Sustained Improvements in Attack-Free Probability and Quality of Life Over 5 Years.
Philip H Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.